MYH14 and necrotizing enterocolitis: The results showed that anti-myosin autoantibodies are able to distinguish NEC from non-NEC, achieving an area under the curve (AUC) of 0.8856, with an AUC of 0.9457 for NEC stage I. Our data suggest that anti-myosin autoantibodies may serve as a biomarker for the diagnosis of NEC, especially in NEC stage I.